Head-to-head · WeighScore
Trimi vs VevaRX
The verdict
Trimi takes it — 86.4/100 to 54.7/100.
Trimi grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Bottom-quartile pricing on both molecules under one flat membership, shipped free nationwide — a strong-value pick sitting just behind the top tier.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Trimi | VevaRX |
|---|---|---|
| WeighScore | 86.4/100 | 54.7/100 |
| Grade | B | C |
| Site position | #4 | #503 |
| Semaglutide | $175/mo month-to-month · $99/mo only on a 12-month prepay ($1,188 in one charge) | $189/mo (the same page also prints $167 a month and $467 for three months) |
| Tirzepatide | $235/mo month-to-month · $125/mo only on a 12-month prepay ($1,500 in one charge) | $467 per three months, auto-renewing (about $155.67 a month; no monthly option is offered) |
| Coverage | All 50 states | 36 states |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #4 · B
Strengths
- Low flat pricing on both semaglutide and tirzepatide
- Both molecules on a single membership
- Free shipping to all 50 states
- Fast dispatch once the prescriber signs off
Where it loses points
- Compounded only — no brand-name Ozempic/Wegovy or Mounjaro/Zepbound
- Injection only — no oral or sublingual route
- Dispensing pharmacy not publicly named
- Shorter public track record than the incumbents
Site position #503 · C
Strengths
- Publishes an exact 36-state list by name rather than a nationwide claim it then hedges
- States what the three-month figure covers — medication, supplies and the provider visit — and includes free two- to three-day shipping
- Unlimited physician access and a 24/7 care team are described as inside the program price
- Prices its peptide products openly beside the GLP-1 lines
Where it loses points
- Tirzepatide has no monthly option: it is sold as $467 for three months on a quarterly auto-renewal with a three-month minimum
- The tirzepatide page's own arithmetic is wrong — it calls $467 equivalent to $149 a month when the figure is $155.67, which the semaglutide page states correctly
- The semaglutide page carries four prices, two of which belong to tirzepatide
- Follow-up consultations are priced separately at $299 and $399, which the program pages do not mention
- NAD+ is priced three different ways on one page, at $399, $447 and $267
- Another company's domain appears in VevaRX's own Terms, in the transaction currency clause
- The contact page FAQ is a different product's copy and gives dosing instructions for a powdered drink under the question of how to take semaglutide or tirzepatide
- Two opposite return policies are live, and no pharmacy, compounding class, clinician or medical group is named anywhere
Featured provider
Trimi
Trimi scores 86.4/100 (B). Bottom-quartile pricing on both molecules under one flat membership, shipped free nationwide — a strong-value pick sitting just behind the top tier.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.